Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors
The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. To characterize the protein tyrosine kinases that are...
Saved in:
Published in: | Annals of surgical oncology Vol. 1; no. 1; pp. 18 - 27 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-01-1994
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas.
To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR.
We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas.
When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases. |
---|---|
AbstractList | BACKGROUNDThe tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas.METHODSTo characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR.RESULTSWe identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas.CONCLUSIONSWhen grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases. The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR. We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas. When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases. |
Author | Weiner, T M Craven, R J Cance, W G Liu, E T |
Author_xml | – sequence: 1 givenname: T M surname: Weiner fullname: Weiner, T M organization: Department of Surgery, University of North Carolina School of Medicine, Chapel Hill – sequence: 2 givenname: E T surname: Liu fullname: Liu, E T – sequence: 3 givenname: R J surname: Craven fullname: Craven, R J – sequence: 4 givenname: W G surname: Cance fullname: Cance, W G |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7834423$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkDtPwzAUhS1UVNrCwo7kiQE14EdiJyNU5SFVYukeOck1CSR2sR3R_nsCjWC6RzqfjnS_OZoYawChS0puKSHy7uGRME54wuUJmtGEx1EsUjoZMhFplDGRnKG59--EUMlJMkVTmfI4ZnyG9uv9zoH3jTXYavzm7FeosVZlsA47KGE3BL_EoQasbalarKoafvGPxigPS6xMhe3QOxwOzvrGwFh53Bhc950y2FsdcGi87wGHvhsmz9GpVq2Hi_Eu0PZxvV09R5vXp5fV_SYqWcpCVEEm0zLTDFjBtUx1yiopMx6LqogLyjRonnHQQpS64DSllCsoqiSOhRCV4At0fZzdOfvZgw951_gS2lYZsL3PpZSMJoIO4M0RLIcfvAOd71zTKXfIKcl_LOf_lgf4alztiw6qP3TUyr8BVAd7Cw |
CitedBy_id | crossref_primary_10_1517_13543776_12_3_369 crossref_primary_10_1016_S0959_8049_98_00247_0 crossref_primary_10_1002__SICI_1098_2744_199905_25_1_73__AID_MC9_3_0_CO_2_U crossref_primary_10_1016_j_exer_2003_10_002 crossref_primary_10_1158_0008_5472_CAN_03_0245 crossref_primary_10_1002_cncr_26334 crossref_primary_10_1016_j_bbrc_2003_10_060 crossref_primary_10_1007_BF02409059 crossref_primary_10_1007_s10549_004_1022_8 crossref_primary_10_1038_modpathol_3800424 crossref_primary_10_1016_j_bbagrm_2008_11_002 crossref_primary_10_1074_jbc_M414172200 crossref_primary_10_3390_ijms23084125 crossref_primary_10_1002_jcb_20046 crossref_primary_10_1016_j_bbaexp_2004_03_002 crossref_primary_10_1016_S0748_7983_03_00120_3 crossref_primary_10_1379_1466_1268_2001_006_0105_GTPOAC_2_0_CO_2 crossref_primary_10_1158_0008_5472_CAN_07_6268 crossref_primary_10_1007_s11864_003_0045_4 crossref_primary_10_5858_1999_123_1246_MPOSTA crossref_primary_10_1016_S0960_7404_03_00004_5 crossref_primary_10_3390_cancers14061561 crossref_primary_10_1186_2053_6844_1_2 crossref_primary_10_1371_journal_pone_0115916 crossref_primary_10_1002_mc_20552 crossref_primary_10_1158_1078_0432_CCR_13_1594 crossref_primary_10_1016_S0167_4889_01_00123_9 crossref_primary_10_1016_j_lungcan_2006_06_001 crossref_primary_10_1074_jbc_M701450200 crossref_primary_10_1002__SICI_1097_0215_19960529_66_5_669__AID_IJC15_3_0_CO_2 crossref_primary_10_1002_ijc_2910600611 crossref_primary_10_1016_j_ejca_2007_10_012 crossref_primary_10_1016_j_ejcb_2020_151083 crossref_primary_10_1053_jhep_2003_50457 crossref_primary_10_1002_pros_10114 crossref_primary_10_1016_S0736_5748_00_00041_1 crossref_primary_10_4236_jct_2012_31002 crossref_primary_10_1007_BF01220799 crossref_primary_10_1042_BC20100094 crossref_primary_10_1007_BF02306088 crossref_primary_10_1016_j_jhep_2004_03_029 crossref_primary_10_1002_cncr_29858 crossref_primary_10_1074_jbc_M205002200 crossref_primary_10_1517_14728220903460340 crossref_primary_10_1529_biophysj_105_074526 crossref_primary_10_1074_jbc_273_27_17102 crossref_primary_10_1097_00129039_200412000_00009 crossref_primary_10_1007_s00280_004_0780_7 crossref_primary_10_1128_MCB_19_12_8075 crossref_primary_10_1002__SICI_1097_0142_19991015_86_6_1551__AID_CNCR23_3_0_CO_2_P crossref_primary_10_1006_excr_1998_4327 crossref_primary_10_1007_BF00123398 |
Cites_doi | 10.1002/ijc.2910390605 10.1128/MCB.12.4.1698 10.1172/JCI113137 10.1016/0092-8674(90)90659-3 10.1016/0960-7404(92)90092-Y 10.1093/nar/12.1Part1.387 10.1126/science.3798106 10.1126/science.3291115 10.1016/0092-8674(90)90801-K 10.1128/MCB.11.10.5016 10.1002/ijc.2910460620 10.1038/319743a0 10.1126/science.1312256 10.1038/358690a0 10.1073/pnas.89.11.5192 10.1016/0092-8674(91)90637-E 10.1016/0735-0651(89)90020-4 10.1038/313745a0 10.1126/science.6538699 10.1002/ijc.2910540409 10.1073/pnas.87.15.5863 10.1073/pnas.86.5.1603 10.1016/0092-8674(91)90639-G 10.1056/NEJM199011223232105 10.1073/pnas.74.12.5463 10.1073/pnas.88.19.8392 10.1016/0896-6273(91)90167-X 10.1126/science.1659742 10.1073/pnas.89.7.2960 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1007/BF02303537 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1534-4681 |
EndPage | 27 |
ExternalDocumentID | 10_1007_BF02303537 7834423 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA01625 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 203 23M 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2WC 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJOOF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAWUL BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C1A CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DIK DL5 DNIVK DPUIP E3Z EBD EBLON EBS ECM EIF EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GX1 GXS H13 HEOXT HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD OWW P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOQ YFH YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c282t-de978c9f2e2b3f78f82d779346db4b12fef393ef66cfb318113aebd544666d63 |
ISSN | 1068-9265 |
IngestDate | Fri Oct 25 23:12:37 EDT 2024 Fri Nov 22 00:56:55 EST 2024 Tue Oct 15 23:15:15 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c282t-de978c9f2e2b3f78f82d779346db4b12fef393ef66cfb318113aebd544666d63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 7834423 |
PQID | 77721561 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_77721561 crossref_primary_10_1007_BF02303537 pubmed_primary_7834423 |
PublicationCentury | 1900 |
PublicationDate | 1994-Jan 1994-1-00 19940101 |
PublicationDateYYYYMMDD | 1994-01-01 |
PublicationDate_xml | – month: 01 year: 1994 text: 1994-Jan |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Annals of surgical oncology |
PublicationTitleAlternate | Ann Surg Oncol |
PublicationYear | 1994 |
References | 2406025 - Cell. 1990 Feb 23;60(4):557-63 1341265 - Surg Oncol. 1992 Aug;1(4):309-14 2466296 - Proc Natl Acad Sci U S A. 1989 Mar;86(5):1603-7 2158859 - Cell. 1990 Apr 20;61(2):203-12 1933904 - Cancer Res. 1991 Dec 1;51(23 Pt 1):6393-6 3883191 - Nature. 1985 Feb 28-Mar 6;313(6005):745-7 1317261 - Cancer Res. 1992 Jun 1;52(11):3213-9 1656220 - Mol Cell Biol. 1991 Oct;11(10):5016-31 2169345 - Cancer Res. 1990 Oct 1;50(19):6344-8 2233918 - N Engl J Med. 1990 Nov 22;323(21):1457-62 1594631 - Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5192-6 1659742 - Science. 1991 Nov 22;254(5035):1146-53 2887586 - J Clin Invest. 1987 Sep;80(3):804-11 271968 - Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 1313574 - Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2960-4 2025425 - Neuron. 1991 May;6(5):691-704 1988147 - Cell. 1991 Jan 25;64(2):249-70 1312667 - Mol Cell Biol. 1992 Apr;12(4):1698-707 2869410 - Nature. 1986 Feb 27-Mar 5;319(6056):743-8 2536861 - Lab Invest. 1989 Feb;60(2):245-53 1309926 - Lab Invest. 1992 Jan;66(1):108-15 1379699 - Nature. 1992 Aug 20;358(6388):690-2 1653246 - J Biol Chem. 1991 Sep 5;266(25):16755-63 1320245 - Oncogene. 1992 Jul;7(7):1355-9 1717976 - Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8392-6 2569437 - Gene Anal Tech. 1989 Jul-Aug;6(4):79-83 6546423 - Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95 2143022 - Proc Natl Acad Sci U S A. 1990 Aug;87(15):5863-7 1656371 - Oncogene. 1991 Sep;6(9):1677-83 6538699 - Science. 1984 Apr 20;224(4646):256-62 1661131 - Cell Growth Differ. 1991 Oct;2(10):495-501 1312256 - Science. 1992 Feb 21;255(5047):989-91 8099900 - Int J Cancer. 1993 Jun 19;54(4):571-7 2841235 - Important Adv Oncol. 1987;:87-104 1314366 - Oncogene. 1992 Apr;7(4):627-33 3291115 - Science. 1988 Jul 1;241(4861):42-52 3473046 - Int J Cancer. 1987 Jun 15;39(6):685-8 3798106 - Science. 1987 Jan 9;235(4785):177-82 1655243 - Cancer Res. 1991 Oct 1;51(19):5087-92 1846320 - Cell. 1991 Jan 25;64(2):281-302 1372158 - Am J Pathol. 1992 Mar;140(3):639-48 2174413 - Int J Cancer. 1990 Dec 15;46(6):1066-70 M Grieco (BF02303537_CR7) 1990; 60 A Ullrich (BF02303537_CR10) 1990; 61 AF Wilks (BF02303537_CR14) 1989; 86 WG Cance (BF02303537_CR25) 1993; 54 B Westermark (BF02303537_CR35) 1991; 51 MB Sporn (BF02303537_CR13) 1985; 313 F Sanger (BF02303537_CR18) 1977; 74 MD Schaller (BF02303537_CR27) 1992; 89 P Leveen (BF02303537_CR28) 1990; 46 SK Hanks (BF02303537_CR8) 1988; 241 WG Cance (BF02303537_CR3) 1990; 323 WA Franklin (BF02303537_CR30) 1990; 50 SA Aaronson (BF02303537_CR11) 1991; 254 WG Cance (BF02303537_CR20) 1992; 1 TP Fleming (BF02303537_CR36) 1992; 7 T Hunter (BF02303537_CR9) 1991; 69 BI Terman (BF02303537_CR22) 1991; 6 PM Meltzer (BF02303537_CR5) 1991; 2 C Lai (BF02303537_CR15) 1991; 6 JP O'Bryan (BF02303537_CR24) 1991; 11 T Kumabe (BF02303537_CR33) 1992; 7 J Devereux (BF02303537_CR19) 1984; 12 CJ Thiele (BF02303537_CR43) 1987; 86 C DeVries (BF02303537_CR23) 1992; 55 J-L Guan (BF02303537_CR39) 1992; 358 MA Israel (BF02303537_CR42) 1987 LC Cantley (BF02303537_CR12) 1991; 64 J Partanen (BF02303537_CR26) 1992; 12 PM Perosio (BF02303537_CR31) 1989; 60 M Hermanson (BF02303537_CR34) 1992; 52 A Smits (BF02303537_CR37) 1992; 140 M Katoh (BF02303537_CR21) 1992; 89 D Martin-Zanca (BF02303537_CR40) 1986; 319 DJ Slamon (BF02303537_CR41) 1984; 224 LJ Kornberg (BF02303537_CR38) 1991; 88 N Mandahl (BF02303537_CR4) 1987; 39 DG Brachman (BF02303537_CR1) 1991; 51 R Jansen (BF02303537_CR17) 1989; 6 J Sambrook (BF02303537_CR16) 1989 C Palman (BF02303537_CR29) 1992; 66 DJ Slamon (BF02303537_CR6) 1987; 235 LM Mulligan (BF02303537_CR2) 1990; 87 M Nister (BF02303537_CR32) 1991; 266 |
References_xml | – volume: 39 start-page: 685 year: 1987 ident: BF02303537_CR4 publication-title: Int J Cancer doi: 10.1002/ijc.2910390605 contributor: fullname: N Mandahl – volume: 50 start-page: 6344 year: 1990 ident: BF02303537_CR30 publication-title: Cancer Res contributor: fullname: WA Franklin – volume: 12 start-page: 1698 year: 1992 ident: BF02303537_CR26 publication-title: Mol Cell Biol doi: 10.1128/MCB.12.4.1698 contributor: fullname: J Partanen – volume: 86 start-page: 804 year: 1987 ident: BF02303537_CR43 publication-title: J Clin Invest doi: 10.1172/JCI113137 contributor: fullname: CJ Thiele – volume: 60 start-page: 557 year: 1990 ident: BF02303537_CR7 publication-title: Cell doi: 10.1016/0092-8674(90)90659-3 contributor: fullname: M Grieco – volume: 1 start-page: 309 year: 1992 ident: BF02303537_CR20 publication-title: Surg Oncol doi: 10.1016/0960-7404(92)90092-Y contributor: fullname: WG Cance – volume: 266 start-page: 16755 year: 1991 ident: BF02303537_CR32 publication-title: J Biochem contributor: fullname: M Nister – volume: 60 start-page: 245 year: 1989 ident: BF02303537_CR31 publication-title: Lab Invest contributor: fullname: PM Perosio – volume: 12 start-page: 387 year: 1984 ident: BF02303537_CR19 publication-title: Nucl Acid Res doi: 10.1093/nar/12.1Part1.387 contributor: fullname: J Devereux – volume: 7 start-page: 1355 year: 1992 ident: BF02303537_CR36 publication-title: Oncogene contributor: fullname: TP Fleming – volume: 52 start-page: 3213 year: 1992 ident: BF02303537_CR34 publication-title: Cancer Res contributor: fullname: M Hermanson – volume: 235 start-page: 177 year: 1987 ident: BF02303537_CR6 publication-title: Science doi: 10.1126/science.3798106 contributor: fullname: DJ Slamon – volume: 241 start-page: 42 year: 1988 ident: BF02303537_CR8 publication-title: Science doi: 10.1126/science.3291115 contributor: fullname: SK Hanks – volume: 61 start-page: 203 year: 1990 ident: BF02303537_CR10 publication-title: Cell doi: 10.1016/0092-8674(90)90801-K contributor: fullname: A Ullrich – volume: 11 start-page: 5016 year: 1991 ident: BF02303537_CR24 publication-title: Mol Cell Biol doi: 10.1128/MCB.11.10.5016 contributor: fullname: JP O'Bryan – volume: 46 start-page: 1066 year: 1990 ident: BF02303537_CR28 publication-title: Int J Cancer doi: 10.1002/ijc.2910460620 contributor: fullname: P Leveen – volume: 319 start-page: 743 year: 1986 ident: BF02303537_CR40 publication-title: Nature doi: 10.1038/319743a0 contributor: fullname: D Martin-Zanca – volume: 55 start-page: 989 year: 1992 ident: BF02303537_CR23 publication-title: Science doi: 10.1126/science.1312256 contributor: fullname: C DeVries – volume: 140 start-page: 639 year: 1992 ident: BF02303537_CR37 publication-title: Am J Pathol contributor: fullname: A Smits – volume: 358 start-page: 690 year: 1992 ident: BF02303537_CR39 publication-title: Nature doi: 10.1038/358690a0 contributor: fullname: J-L Guan – volume: 89 start-page: 5192 year: 1992 ident: BF02303537_CR27 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.11.5192 contributor: fullname: MD Schaller – volume: 69 start-page: 249 year: 1991 ident: BF02303537_CR9 publication-title: Cell doi: 10.1016/0092-8674(91)90637-E contributor: fullname: T Hunter – volume: 6 start-page: 79 year: 1989 ident: BF02303537_CR17 publication-title: Gene Anal Tech doi: 10.1016/0735-0651(89)90020-4 contributor: fullname: R Jansen – volume: 313 start-page: 745 year: 1985 ident: BF02303537_CR13 publication-title: Nature doi: 10.1038/313745a0 contributor: fullname: MB Sporn – volume: 66 start-page: 108 year: 1992 ident: BF02303537_CR29 publication-title: Lab Invest contributor: fullname: C Palman – volume: 224 start-page: 256 year: 1984 ident: BF02303537_CR41 publication-title: Science doi: 10.1126/science.6538699 contributor: fullname: DJ Slamon – volume: 51 start-page: 5087 year: 1991 ident: BF02303537_CR35 publication-title: Cancer Res contributor: fullname: B Westermark – volume: 54 start-page: 571 year: 1993 ident: BF02303537_CR25 publication-title: Int J Cancer doi: 10.1002/ijc.2910540409 contributor: fullname: WG Cance – volume: 87 start-page: 5863 year: 1990 ident: BF02303537_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.87.15.5863 contributor: fullname: LM Mulligan – volume: 86 start-page: 1603 year: 1989 ident: BF02303537_CR14 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.5.1603 contributor: fullname: AF Wilks – volume: 64 start-page: 281 year: 1991 ident: BF02303537_CR12 publication-title: Cell doi: 10.1016/0092-8674(91)90639-G contributor: fullname: LC Cantley – start-page: 87 volume-title: Important advances in oncology year: 1987 ident: BF02303537_CR42 contributor: fullname: MA Israel – volume: 323 start-page: 1457 year: 1990 ident: BF02303537_CR3 publication-title: N Engl J Med doi: 10.1056/NEJM199011223232105 contributor: fullname: WG Cance – volume: 2 start-page: 495 year: 1991 ident: BF02303537_CR5 publication-title: Cell Growth Diff contributor: fullname: PM Meltzer – volume: 74 start-page: 5463 year: 1977 ident: BF02303537_CR18 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.74.12.5463 contributor: fullname: F Sanger – volume: 6 start-page: 1677 year: 1991 ident: BF02303537_CR22 publication-title: Oncogene contributor: fullname: BI Terman – volume: 88 start-page: 8392 year: 1991 ident: BF02303537_CR38 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.88.19.8392 contributor: fullname: LJ Kornberg – volume: 6 start-page: 691 year: 1991 ident: BF02303537_CR15 publication-title: Neuron doi: 10.1016/0896-6273(91)90167-X contributor: fullname: C Lai – volume: 7 start-page: 627 year: 1992 ident: BF02303537_CR33 publication-title: Oncogene contributor: fullname: T Kumabe – volume: 51 start-page: 6393 year: 1991 ident: BF02303537_CR1 publication-title: Cancer Res contributor: fullname: DG Brachman – volume: 254 start-page: 1146 year: 1991 ident: BF02303537_CR11 publication-title: Science doi: 10.1126/science.1659742 contributor: fullname: SA Aaronson – start-page: 7.39 volume-title: Molecular cloning: a laboratory manual year: 1989 ident: BF02303537_CR16 contributor: fullname: J Sambrook – volume: 89 start-page: 2960 year: 1992 ident: BF02303537_CR21 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.7.2960 contributor: fullname: M Katoh |
SSID | ssj0017305 |
Score | 1.7366818 |
Snippet | The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have... BACKGROUNDThe tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers,... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 18 |
SubjectTerms | Amino Acid Sequence Blotting, Northern Cell Adhesion Molecules - genetics Cell Adhesion Molecules - metabolism Focal Adhesion Kinase 1 Focal Adhesion Protein-Tyrosine Kinases Humans Molecular Sequence Data Polymerase Chain Reaction Protein-Tyrosine Kinases - genetics Protein-Tyrosine Kinases - metabolism Receptors, Platelet-Derived Growth Factor - metabolism Sarcoma - genetics Sarcoma - metabolism Soft Tissue Neoplasms - genetics Soft Tissue Neoplasms - metabolism |
Title | Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7834423 https://search.proquest.com/docview/77721561 |
Volume | 1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBZNCqWX0lfoNo8K2tvGsLa0fhxD6pDSbXqoC7kZWY9mCbVDbEP67zPSyHaWpbQ99GKMjIWZ-fxpZjSaIeSDzHgFC7kIYG0zAa8kC0RmokCzVAnG-DIS9rzz-bfk4jL9mPN8iipNY_9V0zAGurYnZ_9B2-OkMAD3oHO4gtbh-ld6z-98aquzA3-Al91d-a46c2A3fWPb61jBWovTNK5WgLrS7oXrdS2w0aINp7uzWfPuF6yj1hTFhy59Fhv7tcDg884pbt71Pxu_L7RVmbntb5Fem1puBvH12h-3Kaag7GrdO35-kL1tOyRhqGDaxDq1aHUJgr47mPJH-fiDyAWS7SIGso2wV8TIxlugQ2b1LI1rNJYT2GL_xZDTDn4VW2Ixmc0S2xdfy7Pvq1VZ5JfFDnkcATs5P_zT53HrCShv6bbI_cdt1rT1M29aMb9xTZyJUjwnz7xvQU8QFC_II12_JE---OyJV-RuwgZtDEVsUMQGHbFxTEHv1CGDDsigqPxjCrigDhd0wIV_1NJ1TR0uqMUFRVxQxMVrUpzlxel54DtvBBJc8C5QOktSCf-sjipmktSkkUpAVjxWFa_CyGjDMqZNHEtTwaoQhkzoSi1tckCsYrZHduum1m8IlZXKdLLgYSZiHmemkrEJo4RLkUgBtvGMvB8EWd5gfZVyqKQ9iXtG3g0yLoH-7J6WqHXTt2UC3mEIPsCM7KHox1lcB5mIvf3jq_vk6YTOA7Lb3fb6kOy0qj9yyLgHMteDuA |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+growth+factor+receptors%2C+the+focal+adhesion+kinase%2C+and+other+tyrosine+kinases+in+human+soft+tissue+tumors&rft.jtitle=Annals+of+surgical+oncology&rft.au=Weiner%2C+T+M&rft.au=Liu%2C+E+T&rft.au=Craven%2C+R+J&rft.au=Cance%2C+W+G&rft.date=1994-01-01&rft.issn=1068-9265&rft.volume=1&rft.issue=1&rft.spage=18&rft.epage=27&rft_id=info:doi/10.1007%2FBF02303537&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon |